Ubs Group Ag Pasithea Therapeutics Corp Wt Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

A detailed history of Ubs Group Ag transactions in Pasithea Therapeutics Corp Wt stock. As of the latest transaction made, Ubs Group Ag holds 34 shares of KTTAW stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Holding current value
$0
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.0 - $0.02 $0 - $0
34 New
34 $0
Q3 2023

Nov 09, 2023
BUY
$0.01 - $0.07 $1 - $7
100 New
100 $0
Q3 2022

Nov 10, 2022
BUY
N/A
250 Added 15.63%
1,849 $0
Q2 2022

Aug 10, 2022
BUY
N/A
799 Added 99.88%
1,599 $0
Q1 2022

May 16, 2022
BUY
N/A
800 New
800 $0
Q4 2021

Feb 14, 2022
SELL
N/A
-45 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
45 New
45 $0

Others Institutions Holding KTTAW

# of Institutions
6
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About PASITHEA THERAPEUTICS CORP WT

KTTAW Quotes by TradingView
  • Ticker KTTAW
  • Sector Healthcare
  • Industry Biotechnology
More about KTTAW
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email